Green Cross Cell has newly appeared among the top-searched stocks.


As of 2:30 p.m. on December 14, Green Cross Cell is trading at 49,450 won, up 1.96% from the previous day. This represents a 20.61% increase compared to November 17. Green Cross Cell is known as a developer and manufacturer of anti-cancer immune cell therapies.

Today, foreign investors are provisionally reported to have made a net sale of 4,000 shares. Over the past five days, individual investors have made a net purchase of 24,831 shares. During the same period, foreign investors recorded a net purchase of 9,707 shares, while institutions made a net sale of 21,910 shares.





[Table] Net Buying/Selling Volume by Foreign Investors and Institutions (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was automatically generated in real time by a news generation algorithm jointly developed by Asia Economy and Thinkpool, a financial AI specialist company.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing